HEERLEN, Netherlands and
EMERYVILLE, California,
December 29, 2017 /PRNewswire/ --
Royal DSM (AEX: DSM.AS), a global science-based
company active in health, nutrition and materials and Amyris,
Inc. (Nasdaq: AMRS), the industrial bioscience company,
today announced that they have closed the transaction for the sale
of Amyris Brasil Ltda to DSM and the establishment of a long-term
manufacturing partnership for Amyris's high-volume
products.
(Logo:
http://photos.prnewswire.com/prnh/20160803/395298LOGO )
The announcement of the intended transaction was made on
November 17, 2017, and the details
can be found here.
DSM - Bright Science. Brighter Living.™
Royal DSM is a global science-based company active in health,
nutrition and materials. By connecting its unique competences in
Life Sciences and Materials Sciences DSM is driving economic
prosperity, environmental progress and social advances to create
sustainable value for all stakeholders simultaneously. DSM delivers
innovative solutions that nourish, protect and improve performance
in global markets such as food and dietary supplements, personal
care, feed, medical devices, automotive, paints, electrical and
electronics, life protection, alternative energy and bio-based
materials. DSM and its associated companies deliver annual net
sales of about €10 billion with approximately 25,000
employees. The company is listed on Euronext Amsterdam. More
information can be found at http://www.dsm.com .
About Amyris
Amyris is the integrated renewable products company that is
enabling the world's leading brands to achieve sustainable growth.
Amyris applies its innovative bioscience solutions to convert plant
sugars into hydrocarbon molecules and produce specialty ingredients
and consumer products. The company is delivering its No Compromise®
products across a number of markets, including specialty and
performance chemicals, flavors and fragrances, cosmetics
ingredients, pharmaceuticals, and nutraceuticals. More information
about the company is available at http://www.amyris.com.
DSM Forward-Looking Statements
This press release may contain forward-looking statements with
respect to DSM's future (financial) performance and position. Such
statements are based on current expectations, estimates and
projections of DSM and information currently available to the
company. DSM cautions readers that such statements involve certain
risks and uncertainties that are difficult to predict and therefore
it should be understood that many factors can cause actual
performance and position to differ materially from these
statements. DSM has no obligation to update the statements
contained in this press release, unless required by law. The
English language version of the press release is leading.
Amyris, the Amyris logo and No Compromise are registered
trademarks of Amyris, Inc. All other trademarks are trademarks of
their respective owners.
http://www.dsm.com
For more information:
DSM Corporate Communications
Herman Betten
tel.
+31-(0)-45-578-2017
e-mail media.contacts@dsm.com
Amyris, Inc.
Peter DeNardo
tel.: +1-(510)-740-7481
e-mail: investor@amyris.com
pr@amyris.com
DSM Investor Relations
Dave Huizing
tel.: +31-(0)-45-578-2864
e-mail: dave.huizing@dsm.com
PDF
- http://mma.prnewswire.com/media/623476/DSM__Amyris_Brazilian_Production_Facility.pdf
PRN NLD